Citation: | ZHOU Wei, GENG Nawei, WANG Ying, ZANG Wei, LIU Bingmu, CAO Liming. The relationship between CT perfusion parameters, short-term efficacy and prognosis after CT-guided microwave ablation of hepatocellular carcinoma[J]. Chinese Journal of General Practice, 2024, 22(10): 1742-1745. doi: 10.16766/j.cnki.issn.1674-4152.003724 |
[1] |
GILLES H, GARBUTT T, LANDRUM J. Hepatocellular Carcinoma[J]. Crit Care Nurs Clin North Am, 2022, 34(3): 289-301. doi: 10.1016/j.cnc.2022.04.004
|
[2] |
杨帆, 曹毛毛, 李贺, 等. 1990—2019年中国人群肝癌流行病学趋势分析及预测[J]. 中华消化外科杂志, 2022, 21(1): 106-113.
YANG F, CAO M M, LI H, et al. Analysis and prediction of the epidemiological trend of liver cancer in the Chinese population from 1990 to 2019[J]. Chinese Journal of Digestive Surgery, 2022, 21(1): 106-113.
|
[3] |
吴景, 毕京浩, 袁蕙芸, 等. 1990—2019年肝癌伤残调整寿命年的研究现状及变化趋势[J]. 中国肿瘤, 2022, 31(11): 915-923.
WU J, BI J H, YUAN H Y, et al. Research status and trends of disability-adjusted life years for liver cancer from 1990 to 2019[J]. Journal of Oncology, 2022, 31(11): 915-923.
|
[4] |
张天澜, 路营, 雷进, 等. 多次微波消融对原发性肝癌患者术后肝功能的影响[J]. 解放军医学院学报, 2023, 44(7): 733-738, 799.
ZHANG T L, LU Y, LEI J, et al. Effect of repeated microwave ablation on postoperative liver function in patients with hepatocellular carcinoma[J]. Academic Journal of Chinese Pla Medical School, 2023, 44(7): 733-738, 799.
|
[5] |
王雅晳, 于杰, 程志刚, 等. 经皮微波消融早期原发性肝癌预后因素分析[J]. 中华超声影像学杂志, 2022, 31(3): 252-259.
WANG Y X, YU J, CHENG Z G, et al. Microwave ablation of early-stage hepatocellular carcinoma affects survival prognostic factors[J]. Chinese Journal of Ultrasonography, 2022, 31(3): 252-259.
|
[6] |
HAJ-MIRZAIAN A, KADIVAR A, KAMEL I R, et al. Updates on imaging of liver tumors[J]. Curr Oncol Rep, 2020, 22(5): 46. DOI: 10.1007/s11912-020-00907-w.
|
[7] |
王德生, 苏庆杰, 夏诗亮, 等. CT灌注成像参数与前循环急性缺血性脑卒中静脉溶栓患者临床转归的相关性[J]. 中国现代医学杂志, 2022, 32(13): 8-14.
WANG D S, SU Q J, XIA S L, et al. Correlation between CTP parameters and clinical outcomes in patients with acute anterior circulation ischemic stroke after intravenous thrombolysis[J]. China Journal of Modern Medicine, 2022, 32(13): 8-14.
|
[8] |
ROMANO F, CHIARELLI M, GARANCINI M, et al. Rethinking the barcelona clinic liver cancer guidelines: intermediate stage and child-pugh B patients are suitable for surgery?[J]. World J Gastroenterol, 2021, 27(21): 2784-2794. doi: 10.3748/wjg.v27.i21.2784
|
[9] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 中华肝脏病杂志, 2020, 28(2): 112-128.
National Health Commission of the People ' s Republic of China Medical Administration. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. Chinese Journal of Hepatology, 2020, 28(2): 112-128.
|
[10] |
LLOVET J M, LENCIONI R. mRECIST for HCC: performance and novel refinements[J]. J Hepatol, 2020, 72(2): 288-306. doi: 10.1016/j.jhep.2019.09.026
|
[11] |
曹毛毛, 李贺, 孙殿钦, 等. 全球肝癌2020年流行病学现状[J]. 中华肿瘤防治杂志, 2022, 29(5): 322-328.
CAO M M, LI H, SUN D Q, et al. Global epidemiology of liver cancer in 2020[J]. Chinese Journal of Cancer Prevention and Treatment, 2022, 29(5): 322-328.
|
[12] |
ANWANWAN D, SINGH S K, SINGH S, et al. Challenges in liver cancer and possible treatment approaches[J]. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314. DOI: 10.1016/j.bbcan.2019.188314.
|
[13] |
周俭, 肖永胜. 肝癌肝移植临床研究现状与展望[J]. 中国实用外科杂志, 2020, 40(1): 37-41.
ZHOU J, XIAO Y S. Present status and progress of clinical liver transplantation for hepatocellular carcinoma[J]. Chinese Journal of Practical Surgery, 2020, 40(1): 37-41.
|
[14] |
IZZO F, GRANATA V, GRASSI R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update[J]. Oncologist, 2019, 24(10): e990-e1005. doi: 10.1634/theoncologist.2018-0337
|
[15] |
JOHNSON W, WEEKLEY A, SUZ P, et al. Safety of CT-guided microwave ablation of subcardiac liver tumors[J]. Cardiovasc Intervent Radiol, 2022, 45(11): 1693-1700. doi: 10.1007/s00270-022-03235-7
|
[16] |
闫兰竹, 乔顺义, 张艳丽, 等. 免疫球蛋白在肝癌TACE治疗过程中的变化及预测疗效的价值[J]. 昆明医科大学学报, 2024, 45(4): 128-134.
YAN L Z, QIAO S Y, ZHANG Y L, et al. Changes of Immunoglobulin in TACE Treatment of Hepatocellular Carcinoma and Its Value in Predicting Curative Effect[J]. Journal of Kunming Medical University, 2024, 45(4): 128-134.
|
[17] |
陆小华, 袁洪新. BTLA、CTLA-4基因多态性与肝癌TACE联合靶向治疗疗效及预后相关性[J]. 昆明医科大学学报, 2023, 44(9): 126-135.
LU X H, YUAN H X. The Analysis of the Correlation between BTLA, CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer[J]. Journal of Kunming Medical University, 2023, 44(9): 126-135.
|
[18] |
陈庭宇, 王涛, 龚齐云, 等. 多层螺旋CT灌注成像评价介入性热化疗治疗中晚期肝癌的价值[J]. 影像科学与光化学, 2020, 38(2): 272-279.
CHEN T Y, WANG T, GONG Q Y, et al. Value of Multi-slice Spiral CT Perfusion Imaging in Evaluating Interventional Thermochemotherapy for Advanced Hepatocellular Carcinoma[J]. Imaging Science and Photochemistry, 2020, 38(2): 272-279.
|
[19] |
孙文杰, 高知玲, 高雨佳, 等. 基于多层螺旋CT全肝灌注成像小肝癌射频消融术后早期血流状态变化的定量评价[J]. 中华肝脏病杂志, 2020, 28(6): 488-493.
SUN W J, GAO Z L, GAO Y J, et al. Quantitative evaluation of early stage blood flow change status after radiofrequency ablation based on multi-slice spiral CT whole-liver perfusion imaging on small hepatocellular carcinoma[J]. Chinese Journal of Hepatology, 2020, 28(6): 488-493.
|
[20] |
盖雪, 李国华, 付荣, 等. 多层螺旋CT灌注扫描联合血清FABP5、SEMA-3B对老年原发性肝癌的诊断和预后评估价值[J]. 中国老年学杂志, 2023, 43(15): 3639-3642.
GAI X, LI G H, FU R, et al. The value of multi-slice spiral CT perfusion scanning combined with serum FABP5 and SEMA-3B in the diagnosis and prognosis of aged primary liver cancer[J]. Chinese Journal of Gerontology, 2023, 43(15): 3639-3642.
|
[21] |
孟明明, 董健, 刘福全, 等. CT肝脏灌注成像对PHC患者TACE术后血流状态的评估[J]. 影像科学与光化学, 2022, 40(4): 837-842.
MENG M M, DONG J, LIU F Q, et al. Evaluation of Blood Flow Status after TACE in PHC Patients by CT Liver Perfusion Imaging[J]. Imaging Science and Photochemistry, 2022, 40(4): 837-842.
|
[22] |
LEWIN M, LAURENT-BELLUE A, DESTERKE C, et al. Evaluation of perfusion CT and dual-energy CT for predicting microvascular invasion of hepatocellular carcinoma[J]. Abdom Radiol (NY), 2022, 47(6): 2115-2127.
|
[23] |
KOBE A, KINDLER Y, KLOTZ E, et al. Fusion of preinterventional MR imaging with liver perfusion CT after RFA of hepatocellular carcinoma: early quantitative prediction of local recurrence[J]. Invest Radiol, 2021, 56(3): 188-196.
|